Clinical Trial Update: Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated adding mirtazapine to dexamethasone and aprepitant for delayed emesis in breast cancer patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aprepitant (aprepitant)
• DEXAMETHASONE (Dexamethasone)
• mirtazapine (mirtazapine)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED